Waist circumference is related to low-grade inflammation in youth

International Journal of Pediatric Obesity

Volumn 5, Issue 4, 2010, Pages 313-319

  Steene Johannessen, Jostein ^a   Kolle, Elin ^a   Reseland, Janne E ^b   Anderssen, Sigmund A ^a   Andersen, Lars Bo ^a,c  

^a NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cardiovascular disease; Cytokine; Obesity; Waist circumference; Youth

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; SCATTER FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; METABOLISM; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; MALE; NORWAY; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 77954779094     PISSN: 17477166     EISSN: 17477174     Source Type: Journal    
DOI: 10.3109/17477160903497035     Document Type: Article

References (41)

1. James PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004;22:276-280
2. Coppack SW. Pro-infl ammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60:349-356
3. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329-339
4. Odrowaz-Sypniewska G. Markers of pro-infl ammatory and pro-thrombotic state in the diagnosis of metabolic syndrome. Adv Med Sci. 2007;52:246-250
5. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol. 2006;64: 355-365
6. Rehman J, Considine RV, Bovenkerk JE et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol. 2003;41:1408-1413
7. Warnberg J, Marcos A. Low-grade infl ammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 2008;19:11-15
8. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
9. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971-1977
10. Haffner SM. The metabolic syndrome: infl ammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97: 3-11A.
11. McGill HC Jr., McMahan CA, Herderick EE et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000;72:1307-15S.
12. Jarvisalo MJ, Harmoinen A, Hakanen M et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 2002;22: 1323-1328
13. Kapiotis S, Holzer G, Schaller G et al. A proinfl ammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol. 2006;26:2541-2546
14. Andersen LB, Wedderkopp N, Hansen HS et al. Biological cardiovascular risk factors cluster in Danish children and adolescents: the European Youth Heart Study. Prev Med. 2003;37:363-367 (Pubitemid 37162689)
15. Saland JM. Update on the metabolic syndrome in children. Curr Opin Pediatr. 2007;19:183-191
16. Huang TT, Ball GD, Franks PW. Metabolic syndrome in youth: current issues and challenges. Appl Physiol Nutr Metab. 2007;32:13-22.
17. Valle M, Martos R, Gascon F et al. Low-grade systemic infl ammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005;31: 55-62.
18. Aygun AD, Gungor S, Ustundag B et al. Proinfl ammatory cytokines and leptin are increased in serum of prepubertal obese children. Mediators Infl amm. 2005;2005(3):180-183
19. S hin JY, Kim SY, Jeung MJ et al. Serum adiponectin, C-reactive protein and TNF-alpha levels in obese Korean children. J Pediatr Endocrinol Metab. 2008;21:23-29
20. Warnberg J, Moreno LA, Mesana MI et al. Infl ammatory mediators in overweight and obese Spanish adolescents. The AVENA Study. Int J Obes Relat Metab Disord. 2004;28 Suppl 3:S59-63.
21. Herder C, Schneitler S, Rathmann W et al. Low-grade infl ammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92:4569-4574
22. Rubin DA, McMurray RG, Harrell JS et al. The association between insulin resistance and cytokines in adolescents: the role of weight status and exercise. Metabolism. 2008;57: 683-690
23. Winer JC, Zern TL, Taksali SE et al. Adiponectin in childhood and adolescent obesity and its association with infl ammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91:4415-4423
24. Steene-Johannessen J, Kolle E, Anderssen SA et al. Cardiovascular disease risk factors in a population-based sample of Norwegian children and adolescents. Scand J Clin Lab Invest. 2009;69:380-386
25. Cole TJ, Bellizzi MC, Flegal KM et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-1243
26. Tanner JM. Growth at adolescence. Oxford: Blackwell; 1962.
27. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419
28. Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol. 2005;28: 408-412
29. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062
30. Zimmet P, Alberti G, Kaufman F et al. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059-2061
31. Ford ES, Galuska DA, Gillespie C et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr. 2001;138:486-492
32. Wu DM, Chu NF, Shen MH et al. Obesity, plasma high sensitivity c-reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39:810-815
33. Warnberg J, Nova E, Moreno LA et al. Infl ammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr. 2006;84:505-512
34. Guran O, Akalin F, Ayabakan C et al. High-sensitivity C-reactive protein in children at risk for coronary artery disease. Acta Paediatr. 2007;96:1214-1219
35. Oliveira AC, Oliveira AM, Almeida MS et al. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth. J Pediatr. 2008;152:337-342
36. Soriano-Guillen L, Hernandez-Garcia B, Pita J et al. Highsensitivity C-reactive protein is a good marker of cardiovascular risk in obese children and adolescents. Eur J Endocrinol. 2008;159:R1-4.
37. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117:2362-2368
38. Bell LN, Ward JL, Degawa-Yamauchi M et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab. 2006;291:E843-8.
39. Hiratsuka A, Adachi H, Fujiura Y et al. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab. 2005;90:2927-2931
40. Jimenez MV, Estepa RM, Camacho RMM et al. Endothelial dysfunction is related to insulin resistance and infl ammatory biomarker levels in obese prepubertal children. Eur J Endocrinol. 2007;156:497-502.
41. Balagopal P, George D, Patton N et al. Lifestyle-only intervention attenuates the infl ammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr. 2005;146:342-348